Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet

Inclusion Criteria: The subjects have to meet all of the following criteria to be eligible to participate in the clinical investigation: 1. Signed informed consent form 2. \> 18 years of age 3. Males and females 4. Tinea Pedis (Athlete's foot) confirmed with total symptom score graded between 6-16 (erythema, erosions, macerations, pruritus, fissures, burning/stinging, hyperkeratosis and odour) using a 4-point severity scale (0=absent, 1=mild, 2=moderate and 3=severe). NOTE! maximum total score is 24. \- Score of 2 (moderate) of higher required in at least 1 of the following; erythema, macerations, pruritus or odur. 5. Score of at least 2 (moderate) required in at least one of the following: heel cracks (rhagades), calluses (hyperkeratosis) and dry feet using a 5-point severity scale (0=absent, 1=mild, 2=moderate, 3=advanced and 4=severe). 6. Patient with confirmed mycological culture Exclusion Criteria: Subjects meeting any of the following criteria will not be permitted to participate in the clinical investigation: 1. Severe tinea pedis interdigitalis (Athlete's foot) total score of severity grading \>16 (signs and symptoms) 2. Women pregnant or lactation at time of enrolment 3. Diagnosed with Diabetes Type I or II 4. Topical medicinal antifungal therapy within 4 weeks prior to study start 5. Treatment with systemic anti fungal therapy including terbinafine, itraconazole or fluconazole within 6 months prior to study start 6. Treatment with local amd/or systemic corticosteroids or immunosuppressant's within 6 weeks prior to study start 7. Any other open wounds/lesions in the area treated with the Investigational device 8. Participated in another Clinical Investigation/Trial the last 3 months 9. Any other medical condition, judged by the investigator may make follow-up or investigation inappropriate